YEASEN Biotechnology

company

About

YEASEN commitment to developing and producing enzyme products.

  • Shanghai,Shanghai,China
  • 501 - 1000

Details

Last Funding Type
Series B
Last Funding Money Raised
¥250M
Industries
Biotechnology,Health Care,Product Research
Founded date
Jan 1, 2014
Number Of Employee
501 - 1000
Operating Status
Active
Legal Name
YEASEN Biotechnology (Shanghai) Co., Ltd.
Also Known As
YEASEN,YEASEN Biotechnology (Shanghai) Co., Ltd.,lifetopstar

Yeasen is a biotechnology company that provides molecular enzymes, proteins, antibodies, nucleic acids, and cells. They produce fields of life science research, diagnosis and detection, and biomedicine.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥250M
YEASEN Biotechnology has raised a total of ¥250M in funding over 2 rounds. Their latest funding was raised on Jun 17, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 17, 2021 Series B ¥250M 2 Legend Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
2
YEASEN Biotechnology is funded by 2 investors. Legend Capital and Step Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Legend Capital Yes Series B
Step Fund Series B

Employee Profiles

Number of Employee Profiles
1
YEASEN Biotechnology has 1 current employee profiles, including Executive Huang Weihua
Executive